Agne Taraseviciute-Morris

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Agne Taraseviciute-Morris is an author at Janssen (United States) specializing in multiple myeloma treatment, immunotherapy, and refractory multiple myeloma.

Publications per year

2021–2023

Publications

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma Not Intended for Transplant: A Randomized, Phase 3 Study (CARTITUDE-5)

Dominik Dytfeld, Binod Dhakal, Mounzer Agha et al. · Blood · 2021 · 41 citations

Pharmacy, Hematology, Pharmacotherapy +16

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

Sharmila Raghunandan, Melinda Pauly, William Blum et al. · Journal for ImmunoTherapy of Cancer · 2023 · 21 citations · Full text

Medicine, Immunology, Oncology +14

1–2 of 2